 The investigators project aimed at testing whether fluoxetine can reduce the risk of ictalpost-ictal hypoxemia by performing a double-blind, randomized, placebo-controlled trial in patients undergoing video-EEG monitoring as part of the pre-surgical evaluation of their focal drug-resistant epilepsy. 